Rheumatology and Internal Medicine, Rheumatology Research Center, Amir-Alam Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Department of Medical Genetics, Semnan University of Medical Sciences, Semnan, Iran.
Mol Biol Rep. 2022 Dec;49(12):11821-11828. doi: 10.1007/s11033-022-07922-z. Epub 2022 Oct 10.
IL-23 receptor (IL-23R) dysregulation has been shown to have critical roles in pathogenesis of different autoimmune diseases including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) via suppression of regulatory T cells (Tregs) as well as differentiation, expansion, and survival of T helper 17 (Th17) cells, followed by upregulation of interleukin 17 (IL-17). Here, we assessed the association of a functional microRNAs (miRNAs)-related single nucleotide polymorphism (miR-SNPs: rs10889677) in IL-23R, which was correlated with its overexpression and increased risk for SLE and RA in the Iranian population.
Genotype and allele distribution of rs10889677 variant were investigated in 105 RA patients, 100 SLE cases and 105 healthy controls via polymerase chain reaction- restriction fragment length polymorphism (PCR-RFLP) method.
Our findings suggested that AA genotype, but not AC genotype, was associated with increased risk of RA (AA vs. CC; OR: 3.27; 95%CI [1.467-7.551]). The allele A was more frequent in RA group compared to controls (A allele vs. C allele; OR: 1.92; 95%CI [1.282-2.894]). This common variant was not significantly correlated with SLE risk in our population (P > 0.05). However, stratification analysis indicated that RA patients with AA genotype show higher serum concentration levels of C-reactive protein (CRP) (P: 0.008). No obvious correlation was noticed between different genotypes in SLE cases, except for a slight difference in terms of oral ulcer manifestation incidence (P: 0.038).
This study suggests a significant relationship between rs10889677 variant in IL-23R with increased risk of RA and some clinical features in RA and SLE patients.
白细胞介素 23 受体 (IL-23R) 的失调已被证明在包括系统性红斑狼疮 (SLE) 和类风湿关节炎 (RA) 在内的不同自身免疫性疾病的发病机制中具有关键作用,其通过抑制调节性 T 细胞 (Tregs) 以及 Th17 细胞的分化、扩增和存活,从而上调白细胞介素 17 (IL-17)。在这里,我们评估了伊朗人群中与 IL-23R 过度表达和 SLE 和 RA 风险增加相关的功能性 microRNAs (miRNAs)-相关单核苷酸多态性 (miR-SNPs: rs10889677) 的关联。
通过聚合酶链反应-限制性片段长度多态性 (PCR-RFLP) 方法,在 105 例 RA 患者、100 例 SLE 病例和 105 例健康对照中研究了 rs10889677 变异的基因型和等位基因分布。
我们的研究结果表明,AA 基因型而非 AC 基因型与 RA 风险增加相关(AA 与 CC;OR:3.27;95%CI [1.467-7.551])。与对照组相比,RA 组中 A 等位基因更为常见(A 等位基因与 C 等位基因;OR:1.92;95%CI [1.282-2.894])。在我们的人群中,这种常见变异与 SLE 风险无显著相关性(P > 0.05)。然而,分层分析表明,AA 基因型的 RA 患者具有更高的 C 反应蛋白 (CRP) 血清浓度水平(P:0.008)。除了在口腔溃疡表现发生率方面存在细微差异(P:0.038)外,在 SLE 病例中不同基因型之间未观察到明显相关性。
本研究表明,IL-23R 中 rs10889677 变异与 RA 风险增加以及 RA 和 SLE 患者的某些临床特征之间存在显著关系。